Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
King-Prebiotics is a high-tech biotechnology company based in China that specializes in the research, development, and large-scale production of prebiotic fibers, specifically Galacto-oligosaccharides (GOS). The company operates one of the largest GOS production facilities globally, utilizing advanced enzymatic synthesis technology to produce high-purity prebiotic ingredients for the infant formula, functional food, and dietary supplement industries. Their product portfolio includes various grades of GOS in both powder and syrup forms, designed to promote gut health by stimulating the growth of beneficial bacteria like Bifidobacteria. King-Prebiotics maintains rigorous quality standards, holding certifications such as ISO, HACCP, and HALAL to serve a global customer base in the nutrition and healthcare sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on King-Prebiotics.